Publication & Citation Trends
Publications
84 total
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Cited by 811
OpenAlex
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
Cited by 585
OpenAlex
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
Cited by 2,212
OpenAlex
Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer PDF
Cited by 537
OpenAlex
Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer PDF
Cited by 547
OpenAlex
Research Topics
Cancer Treatment and Pharmacology
(18)
Sarcoma Diagnosis and Treatment
(17)
Breast Cancer Treatment Studies
(15)
Vascular Tumors and Angiosarcomas
(15)
Lymphoma Diagnosis and Treatment
(9)
Affiliations
University of the Sciences
Goethe University Frankfurt
American Society of Clinical Oncology
Sunnybrook Health Science Centre
Memorial Sloan Kettering Cancer Center